Effects of PA-1 Transcriptional Regulation on Monocyte Function
Angiotensin, the Vascular Endothelium, and Fibrinolysis - The Effects of PAI-1 Transcriptional Regulation on Human Monocyte Function
Sponsor: National Institutes of Health (NIH)
Terminated
Investigator left institution
Other terminated trials from National Institutes of Health (NIH)
- Adolescent Behavior · Phase PHASE2 · Mar 2025
- Diet, Food Choice, Taste · Phase NA · Dec 2021
- Clostridium Difficile · Phase PHASE2 · Sep 2021
- Epilepsy · May 2020
- Failed Back Surgery Syndrome · Phase NA · Mar 2020
See all terminations from National Institutes of Health (NIH)
Other Atherosclerosis trials with similar outcome
Listed as NCT00512369, this observational or N/A phase trial focuses on Atherosclerosis and remains terminated or withdrawn. Sponsored by National Institutes of Health (NIH), it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Mar 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institutes of Health (NIH)
- Vanderbilt University
For direct contact, visit the study record on ClinicalTrials.gov .